Delivery Order SPE2DB24D1104-SPE2DB24FYCM0

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,087.80, is for the delivery of Cosentyx Unoready 300 mg pen, a specialty medication. The contract has a firm fixed price and has an ultimate completion date of May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,939.36 firm fixed-price contract is for the delivery of Cosentyx Unoready 300 mg pen, 2 ml, and has a completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx Unoready 300 mg pens, a specialty pharmaceutical product. The contract has a total ceiling value of $21,761.71 and a period of performance through May 6, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,695.43, is for the delivery of Cosentyx Unoready 300 mg pens, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period extending to May 15, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx Unoready 300 mg pen injectors. The contract has a ceiling value of $37,838.16 and a period of performance through May 8, 2025. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,001.72, is for the delivery of Cosentyx Unoready 300 mg pen, a specialty medication. The contract has a firm fixed price pricing type and a completion date of February 7, 2025. There is no set-aside designation indicated for this contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx Unoready 300 mg pen 2 ml, a medication, with a ceiling value of $10,865.79 and a period of performance through June 16, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Cosentyx Unoready 300 mg pen. The contract has a ceiling value of $1,521.95 and a completion date of May 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cosentyx Unoready 300 mg pens, a prescription medication, with a ceiling value of $5,925.55 and a period of performance through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,438.34, is for the delivery of the pharmaceutical product Cosentyx Unoready 300 mg pen 2 ml. The contract has a firm fixed price pricing type and an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp is a for-profit organization and is not designated as a set-aside...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYCM0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $6,087.80 firm fixed-price contract is for the supply of Cosentyx Unoready 300 mg pen 2 ml, a specialty medication. The contract has a completion date of September 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs nationwide.

Generated 12/4/24, 9:36 AM